Wide Ranks

ELUT

Elutia, Inc.

4.19

Top Statistics
Market Cap 144 M Forward PE -3.81 Revenue Growth -0.90 %
Current Ratio 0.76 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -261.08 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -6.75 Enterprise / Revenue 5.04 Price To Sales Trailing12 Months 5.80
Profitability
Profit Margins -261.08 % Operating Margins -98.89 %
Balance Sheet
Total Cash 18 M Total Cash Per Share 0.5340 Total Debt 22 M
Total Debt To Equity Current Ratio 0.76 Book Value Per Share -1.66
All Measures
Short Ratio 332.00 % Message Board Id finmb_317199458 Fax 678 680 5486
Shares Short Prior Month 100676 City Silver Spring Uuid b1d6f503-50ec-35a3-be2b-9b2d98f90f72
Previous Close 4.00 First Trade Date Epoch Utc 1 B Book Value -1.66
Beta 0.7600 Total Debt 22 M Volume 91881
Fifty Two Week Low 1.77 Total Cash Per Share 0.5340 Total Revenue 24 M
Shares Short Previous Month Date 1 B Target Median Price 10.00 Audit Risk 4
Max Age 86400 Recommendation Mean 1.00 Sand P52 Week Change 0.3133
Operating Margins -98.89 % Target Mean Price 10.00 Net Income To Common -70092000
Short Percent Of Float 0.0054 Implied Shares Outstanding 34 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 39230 Average Volume10days 39230
Total Cash 18 M Next Fiscal Year End 1 B Revenue Per Share 1.12
Held Percent Insiders 0.0698 Ebitda Margins -74.65 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 8
Regular Market Previous Close 4.00 Target Low Price 10.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 3.73 Open 4.06 Free Cashflow 490125
State MD Dividend Yield 0.00 % Return On Assets -0.2916
Time Zone Short Name EST Board Risk 4 Trailing Eps -2.35
Day Low 4.06 Address1 12510 Prosperity Drive Shares Outstanding 30 M
Compensation Risk 9 Price Hint 4 Target High Price 10.00
Website https://elutia.com 52 Week Change 1.29 Average Volume 37417
Forward Eps -1.10 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 54.50 % Is_sp_500 False Regular Market Day High 4.77
Profit Margins -261.08 % Fifty Two Week High 5.24 Day High 4.77
Shares Short 109381 Regular Market Open 4.06 Industry Key medical-devices
Earnings Growth 0.00 % Enterprise To Revenue 5.04 Revenue Growth -0.90 %
Shares Percent Shares Out 0.0032 Operating Cashflow -21179000 Currency USD
Time Zone Full Name America/New_York Market Cap 144 M Is_nasdaq_100 False
Zip 20904 Quote Type EQUITY Industry Medical Devices
Long Name Elutia Inc. Overall Risk 8 Regular Market Day Low 4.06
Held Percent Institutions 0.7162 Current Price 4.19 Address2 Suite 370
Enterprise To Ebitda -6.75 Financial Currency USD Current Ratio 0.76
Gross Margins 42.45 % Industry Disp Medical Devices Number Of Analyst Opinions 2
Country United States Float Shares 17 M Two Hundred Day Average 3.58
Governance Epoch Date 1 B Enterprise Value 125 M Price To Sales Trailing12 Months 5.80
Forward PE -3.81 Regular Market Volume 91881 Ebitda -18652000
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States.

The company operates in three segments: Device Protection; Women's Health; and Cardiovascular.

It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.

The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device.

In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature.

Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy.

It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors.

The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023.

Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.